Clinician Specialty and HIV PrEP Prescription Reversals and Abandonments

被引:5
|
作者
Bakre, Shivani [1 ]
Chang, Hsien-Yen [2 ]
Doshi, Jalpa A. [3 ,4 ]
Goedel, William C. [5 ]
Saberi, Parya [6 ]
Chan, Philip A. [7 ]
Nunn, Amy [7 ]
Dean, Lorraine T. [1 ,2 ]
机构
[1] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA
[2] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA
[3] Univ Penn, Perelman Sch Med, Philadelphia, PA USA
[4] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA USA
[5] Brown Univ, Sch Publ Hlth, Dept Epidemiol, Providence, RI USA
[6] Univ Calif San Francisco, Dept Med, San Francisco, CA USA
[7] Brown Univ, Dept Med, Providence, RI USA
基金
美国国家卫生研究院;
关键词
PREEXPOSURE PROPHYLAXIS; PATIENT ADHERENCE; PROVIDERS;
D O I
10.1001/jamainternmed.2024.3998
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Importance Clinicians are a key component of preexposure prophylaxis (PrEP) care. Yet, no prior studies have quantitatively investigated how PrEP adherence differs by clinician specialty. Objective To understand the association between prescribing clinician specialty and patients not picking up (reversal/abandonment) their initial PrEP prescription. Design, Setting, and Participants This cross-sectional study of patients who were 18 years or older used pharmacy claims data from 2015 to 2019 on new insurer-approved PrEP prescriptions that were matched with clinician data from the US National Plan and Provider Enumeration System. Data were analyzed from January to May 2022. Main Outcomes and Measures Clinician specialties included primary care practitioners (PCPs), infectious disease (ID), or other specialties. Reversal was defined as a patient not picking up their insurer-approved initial PrEP prescription. Abandonment was defined as a patient who reversed and still did not pick their prescription within 365 days. Results Of the 37 003 patients, 4439 (12%) were female and 32 564 (88%) were male, and 77% were aged 25 to 54 years. A total of 24 604 (67%) received prescriptions from PCPs, 3571 (10%) from ID specialists, and 8828 (24%) from other specialty clinicians. The prevalence of reversals for patients of PCPs, ID specialists, and other specialty clinicians was 18%, 18%, and 25%, respectively, and for abandonments was 12%, 12%, and 20%, respectively. After adjusting for confounding, logistic regression models showed that, compared with patients who were prescribed PrEP by a PCP, patients prescribed PrEP by ID specialists had 10% lower odds of reversals (odds ratio [OR], 0.90; 95% CI, 0.81-0.99) and 12% lower odds of abandonment (OR, 0.88; 95% CI, 0.78-0.98), while patients prescribed by other clinicians had 33% higher odds of reversals (OR, 1.33; 95% CI, 1.25-1.41) and 54% higher odds of abandonment (OR, 1.54; 95% CI, 1.44-1.65). Conclusion The results of this cross-sectional study suggest that PCPs do most of the new PrEP prescribing and are a critical entry point for patients. PrEP adherence differs by clinician specialties, likely due to the populations served by them. Future studies to test interventions that provide adherence support and education are needed.
引用
收藏
页码:1204 / 1211
页数:8
相关论文
共 50 条
  • [21] Understanding HIV Care Provider Attitudes Regarding Intentions to Prescribe PrEP
    Castel, Amanda D.
    Feaster, Daniel J.
    Tang, Wenze
    Willis, Sarah
    Jordan, Heather
    Villamizar, Kira
    Kharfen, Michael
    Kolber, Michael A.
    Rodriguez, Allan
    Metsch, Lisa R.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2015, 70 (05) : 520 - 528
  • [22] Oral PrEP for HIV prevention. It works
    Pool, Erica
    Youssef, Elaney
    Fisher, Martin
    JOURNAL OF VIRUS ERADICATION, 2015, 1 (03) : 168 - 172
  • [23] Understanding the Association between PrEP Stigma and PrEP Cascade Moderated by the Intensity of HIV Testing
    Zhang, Chen
    Liu, Yu
    TROPICAL MEDICINE AND INFECTIOUS DISEASE, 2022, 7 (05)
  • [24] Moving HIV PrEP from research into practice
    Landovitz, Raphael J.
    Coates, Thomas J.
    LANCET INFECTIOUS DISEASES, 2014, 14 (09) : 781 - 783
  • [25] How to incorporate HIV PrEP into your practice
    Stewart, Jenell
    Stekler, Joanne D.
    JOURNAL OF FAMILY PRACTICE, 2019, 68 (05) : 254 - 261
  • [26] Student perceptions of PrEP in an advanced HIV elective
    McKeirnan, Kimberly C.
    Kherghehpoush, Sorosh
    Gladchuk, Angie
    Patterson, Shannon
    Min, Amy
    Crutchley, Rustin D.
    PHARMACY EDUCATION, 2022, 22 (01): : 936 - 943
  • [27] Delivering PrEP to adults with "low" or "no" HIV risk and youth: experiences and perspectives of PrEP providers
    Brooks, Ronald A.
    Nieto, Omar
    Cabral, Alejandra
    Landrian, Amanda
    Fehrenbacher, Anne E.
    CULTURE HEALTH & SEXUALITY, 2022, 24 (01) : 95 - 108
  • [28] Let Me Prep You to PREP Me: Amplifying the Voices of Black Women and Their Providers to Consider PrEP as an HIV Prevention Option
    Chandler, Rasheeta
    Guillaume, Dominique
    Wells, Jessica
    Hernandez, Natalie
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (03)
  • [29] "Far More than Just a Prescription": Focus Groups With US Family Planning Providers and Staff About Integrating PrEP for HIV Prevention Into Their Work
    Razon, Na'amah
    Rodriguez, Amanda
    Carlson, Kimberly
    Witt, Jacki
    Logan, Rachel
    Chambers, Brittany
    Weber, Shannon
    Seidman, Dominika
    WOMENS HEALTH ISSUES, 2021, 31 (03) : 294 - 300
  • [30] Assessing pharmacy students' HIV pre-exposure prophylaxis (PrEP) prescribing knowledge, PrEP attitudes, and HIV-related stigma
    Bustria, Celeste Noelle
    Yohannes, Finan
    Cocohoba, Jennifer
    Nguyen, Lee
    Patel, Nimish
    Saberi, Parya
    JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, 2024, 7 (11): : 1107 - 1113